Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Founder urges state translational fund to bridge medtech ‘valley of death’
Summary
A Cervia Neurosciences co‑founder told the Assembly committee that California lacks mid‑stage non‑dilutive funding for medtech, which risks losing innovations; she proposed a targeted state translational fund (low‑tens of millions) to de‑risk companies and attract private capital.
Ida Garakani Goode, co‑founder and chief operating officer of Cervia Neurosciences, told the Assembly Select Committee the central barrier to bringing some medtech innovations to market is the translational ‘‘valley of death’’ — the capital‑intensive phase between discovery and revenue where safety and regulatory requirements remain high but private investors are reluctant to lead.
Cervia’…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
